1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
HOME > BUSINESS
BUSINESS
- Japan Should Invest More in Whole Genome Sequencing and Interpretation of Cancer-related Genomic Abnormalities: Dr Nakagawa of RIKEN
January 9, 2013
- BONAC Offers Solutions to Overcome Difficulties Faced in Development of Nucleic Acid Medicines: Managing Director Mizutani
January 9, 2013
- Nippon Kayaku Ups FY2012 Outlook for Pharma Biz, Anticancer Generics Brisk
January 8, 2013
- Abbott Japan’s Spin-Off AbbVie G.K. Starts Operations in January with CEO Winer
January 8, 2013
- “Appropriate Expressions” of Disease Awareness Ads Being Tested
January 7, 2013
- Sanofi K.K. Acquires DPP-4, SGLT-2 Inhibitors from Novartis, Chugai Aiming for Growth of Its Own Major Products for Diabetes through Synergism
January 7, 2013
- Lilly and BI in Long-term Collaboration; AZ and BMS Expanding Product Lineup
January 7, 2013
- Kowa Acquires 2 Major Products for “Post-Livalo” Era; How to Avoid Competition between Partners Holds Key in Comarketing
January 7, 2013
- Kyowa Kirin to Enhance Nephrology Lineup with DPP-4 Inhibitor; Companies Aiming to Capture Market through “2-Sword” Strategy
January 7, 2013
- Yoshindo, Ajinomoto Pharmaceuticals to Establish Joint Venture in Infusion and Dialysis Business
December 28, 2012
- Kissei Submits Application for Additional Indications for Combination Therapy of Glufast and DPP-4 Inhibitor or Biguanide
December 28, 2012
- Takeda Terminates Agreement with US Company on Anti-Obesity Drug Development
December 27, 2012
- Mitsubishi Chemical HD to Acquire Qualicaps
December 27, 2012
- Otsuka, Lundbeck File MAA for Abilify Once-Monthly Formulation with EMA
December 27, 2012
- Janssen Pharmaceutical Files for Additional Indication of Chronic Pain for OneDuro Patch
December 26, 2012
- Terumo Forms Alliance with AngioCare of China for Renal Denervation Catheter
December 26, 2012
- Takeda to Establish Global Customer Market Business Insights Department
December 26, 2012
- Takeda Voluntarily Recalls Ethical Version of Alinamin-F5 Injection
December 26, 2012
- Immunotherapeutic Cancer Drug Fails to Meet Primary Endpoint in PIII Study: Merck Serono
December 25, 2012
- Mortality Rate of Patients After Major Bleeds Significantly Lower with Dabigatran: BI
December 25, 2012
ページ
In late January, a bill to amend the Pharmaceuticals and Medical Devices Act cleared key legislation review processes by the…
A Japanese health ministry panel on December 26 wrapped up its discussions on the next amendment of the Pharmaceuticals and…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…